RCEL NASDAQ
AVITA Medical, Inc.
1W: +2.8%
1M: -4.1%
3M: -6.5%
YTD: +29.1%
1Y: -33.1%
3Y: -63.1%
5Y: -78.2%
$4.58
+0.10 (+2.23%)
Weekly Expected Move ±8.5%
$4
$4
$5
$5
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
By Geography
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$72M
+11.5% ▲
5Y CAGR: +19.6%
Gross Profit
$59M
+6.6% ▲
5Y CAGR: +20.4%
Operating Income
-$42M
+25.9% ▲
Net Income
-$49M
+21.4% ▲
EPS (Diluted)
$-1.74
+27.2% ▲
EBITDA
-$40M
+28.4% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $33M | $34M | $50M | $64M | $72M |
| YoY Growth | +13.0% | +4.2% | +45.7% | +28.1% | +11.5% |
| Cost of Revenue | $6M | $6M | $8M | $9M | $13M |
| Gross Profit | $27M | $28M | $42M | $55M | $59M |
| Gross Margin | 81.5% | 82.4% | 84.5% | 85.8% | 82.1% |
| R&D Expenses | $16M | $14M | $21M | $20M | $21M |
| SG&A Expenses | $37M | $45M | $66M | $91M | $80M |
| Operating Expenses | $52M | $56M | $85M | $112M | $101M |
| Operating Income | -$25M | -$28M | -$43M | -$57M | -$42M |
| Operating Margin | -76.1% | -79.9% | -85.1% | -88.1% | -58.6% |
| Interest Expense | $29K | $0 | $1M | $5M | $5M |
| Income Before Tax | -$25M | -$27M | -$35M | -$62M | -$49M |
| Tax Expense | $42K | $36K | $66K | $54K | $11K |
| Net Income | -$25M | -$27M | -$35M | -$62M | -$49M |
| Net Margin | -76.1% | -77.5% | -70.6% | -96.3% | -67.8% |
| EPS (Diluted) | $-1.03 | $-1.57 | $-1.40 | $-2.39 | $-1.74 |
| EBITDA | -$24M | -$26M | -$34M | -$55M | -$40M |
| Shares Outstanding | 24M | 25M | 25M | 26M | 28M |